David J Browning
Overview
Explore the profile of David J Browning including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
2252
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Nassar S, Tarbett A, Browning D
Clin Ophthalmol
. 2020 Sep;
14:2609-2623.
PMID: 32982154
The structure and functions of the choroid have been long acknowledged but the pathophysiology behind various anomalies has been difficult to understand until the advent of optical coherence tomography (OCT)....
12.
Yokogawa N, Ohno-Tanaka A, Hashiguchi M, Shimizu M, Ozawa H, Ueno S, et al.
Arthritis Rheumatol
. 2020 Aug;
73(2):358-359.
PMID: 32856370
No abstract available.
13.
Browning D, Yokogawa N, Greenberg P, Perlman E
Am J Ophthalmol
. 2020 Jul;
219:101-106.
PMID: 32610049
Purpose: To describe the rationale for revising the hydroxychloroquine (HCQ) dosing and screening guidelines and to identify the barriers to more effective guidelines in the future. Design: Literature review. Methods:...
14.
Rosenfeld P, Browning D
Am J Ophthalmol
. 2020 Jun;
216:A7-A8.
PMID: 32505363
No abstract available.
15.
Mansour S, Browning D, Wong K, Flynn Jr H, Bhavsar A
Clin Ophthalmol
. 2020 Mar;
14:653-678.
PMID: 32184554
Purpose: To review the current therapeutic options for the management of diabetic retinopathy (DR) and diabetic macular edema (DME) and examine the evidence for integration of laser and pharmacotherapy. Methods:...
16.
Browning D, Easterbrook M, Lee C
Ophthalmol Retina
. 2019 Aug;
3(10):809-813.
PMID: 31400965
Purpose: The increasing prevalence of obesity over the past 60 years implies the need to reassess the risk of hydroxychloroquine retinopathy (HR) in obese women using the American Academy of...
17.
Punjabi O, Browning D, Clark L, Antoszyk A
Am J Ophthalmol Case Rep
. 2019 Jun;
15:100491.
PMID: 31249904
Purpose: To discuss two striking cases of ophthalmomyiasis interna posterior, in which the larval stage of a botfly is found in the posterior segment. Observations: In the first case, the...
18.
Baker C, Glassman A, Beaulieu W, Antoszyk A, Browning D, Chalam K, et al.
JAMA
. 2019 May;
321(19):1880-1894.
PMID: 31037289
Importance: Intravitreous injections of antivascular endothelial growth factor agents are effective for treating diabetic macular edema (DME) involving the center of the macula (center-involved DME [CI-DME]) with visual acuity impairment...
19.
Stewart M, Browning D, Landers M
Indian J Ophthalmol
. 2018 Nov;
66(12):1751-1762.
PMID: 30451175
Twenty-five percent of diabetes-related vision loss stems from complications of proliferative diabetic retinopathy (PDR). Panretinal photocoagulation has been the preferred treatment of high-risk PDR for decades and more recently intravitreal...
20.
Browning D, Stewart M, Lee C
Indian J Ophthalmol
. 2018 Nov;
66(12):1736-1750.
PMID: 30451174
Diabetic macular edema (DME) is the most common cause of vision loss in patients with diabetic retinopathy with an increasing prevalence tied to the global epidemic in type 2 diabetes...